Product Information

CORLANOR 7.5 MG TABLET is a brand product labeled by Amgen Inc., priced at $9.9947 per EA under NDC 55513081060. Its NADAC has been published 510 times since Sep 21, 2016.

The High Outlier badge above means this manufacturer's average price in the ivabradine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

CORLANOR 7.5 MG TABLET

ivabradine
$9.9947per EA
High Outlier

Strength

7.5 mg/1

Manufacturer

Amgen Inc.

NDC

55513081060

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

IVABRADINE HYDROCHLORIDE

Approval Type

New Drug (NDA)

FDA Application

NDA206143

On Market Since

4/20/2015

Pharmacological Classes

Hyperpolarization-activated Cyclic Nucleotide-gated Channel Antagonists
Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker

Price Statistics

The NADAC for CORLANOR 7.5 MG TABLET has been published 510 times since Sep 21, 2016, and over the history we have for it it has risen 60.5%. The table below summarizes its recorded NADAC range and movement.

Current price$9.9947 per EA
All-time high$10.0213 (Sep 10, 2025)
All-time low$6.2258 (Sep 21, 2016)
52-week high$10.0213
52-week low$9.9839
Median price$7.8633
Average price$8.1520
Largest weekly change+5.9% (Feb 3, 2021)
Weeks tracked510
Tracking sinceSep 21, 2016

Price History

1W

0.0%

1M

+0.1%

3M

+0.1%

6M

-0.1%

1Y

-0.3%

3Y

+10.0%

5Y

+27.1%

All

+60.5%

Generic Alternatives

The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 93% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 93%

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of CORLANOR 7.5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for CORLANOR 7.5 MG TABLET, manufactured by Amgen Inc., is $9.9947 per EA (NDC 55513081060), effective Jun 24, 2026.

How has the price of CORLANOR 7.5 MG TABLET changed over time?

Over the history we have for it, the NADAC for CORLANOR 7.5 MG TABLET has risen 60.5%. It has been tracked across 510 weekly CMS publications since Sep 21, 2016.

What are the highest and lowest recorded NADAC prices for CORLANOR 7.5 MG TABLET?

Since Sep 21, 2016, the NADAC for CORLANOR 7.5 MG TABLET has ranged from a low of $6.2258 (Sep 21, 2016) to a high of $10.0213 (Sep 10, 2025), with a median of $7.8633 per EA.

Are there cheaper alternatives to CORLANOR 7.5 MG TABLET?

Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, IVABRADINE HCL 7.5 MG TABLET, is $0.7371 per EA — about 93% below CORLANOR 7.5 MG TABLET.

Who manufactures CORLANOR 7.5 MG TABLET?

CORLANOR 7.5 MG TABLET (NDC 55513081060) is labeled by Amgen Inc., and CMS classifies it as a brand product.

Related Drugs

Same classification

No related drugs found.